Bioneer Corporation (064550) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bioneer Corporation (064550) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩860.54 Million ≈ $583.18K USD) by net assets (₩229.21 Billion ≈ $155.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 064550 company net worth for the company's overall valuation and market capitalisation.
Bioneer Corporation - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Bioneer Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bioneer Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioneer Corporation ranked by their cash flow conversion efficiency. Explore 064550 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cornish Metals Inc.
V:CUSN
|
-0.014x |
|
KB Star REIT Co. Ltd.
KO:432320
|
0.005x |
|
Aqualis ASA
OL:AQUA
|
-0.048x |
|
T.K.S. Technologies Public Company Limited
BK:TKS
|
0.027x |
|
Singatron Enterprise Co Ltd
TWO:6126
|
0.010x |
|
Bharat Wire Ropes Limited
NSE:BHARATWIRE
|
0.069x |
|
Readytech Holdings Ltd
AU:RDY
|
0.143x |
|
Mirae Corporation
KO:025560
|
0.038x |
Annual Cash Flow Conversion Efficiency for Bioneer Corporation (2014–2024)
The table below shows the annual cash flow conversion efficiency of Bioneer Corporation from 2014 to 2024. View 064550 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩226.89 Billion ≈ $153.76 Million |
₩-13.48 Billion ≈ $-9.13 Million |
-0.059x | -437.31% |
| 2023-12-31 | ₩234.88 Billion ≈ $159.17 Million |
₩4.14 Billion ≈ $2.80 Million |
0.018x | -52.80% |
| 2022-12-31 | ₩236.00 Billion ≈ $159.94 Million |
₩8.81 Billion ≈ $5.97 Million |
0.037x | -85.75% |
| 2021-12-31 | ₩203.05 Billion ≈ $137.60 Million |
₩53.17 Billion ≈ $36.04 Million |
0.262x | -60.16% |
| 2020-12-31 | ₩145.61 Billion ≈ $98.68 Million |
₩95.71 Billion ≈ $64.86 Million |
0.657x | +459.95% |
| 2019-12-31 | ₩30.61 Billion ≈ $20.74 Million |
₩-5.59 Billion ≈ $-3.79 Million |
-0.183x | +12.25% |
| 2018-12-31 | ₩38.99 Billion ≈ $26.42 Million |
₩-8.11 Billion ≈ $-5.50 Million |
-0.208x | -44.77% |
| 2017-12-31 | ₩27.15 Billion ≈ $18.40 Million |
₩-3.90 Billion ≈ $-2.64 Million |
-0.144x | +8.26% |
| 2016-12-31 | ₩26.11 Billion ≈ $17.70 Million |
₩-4.09 Billion ≈ $-2.77 Million |
-0.157x | -1427.23% |
| 2015-12-31 | ₩34.53 Billion ≈ $23.40 Million |
₩407.68 Million ≈ $276.28K |
0.012x | +108.26% |
| 2014-12-31 | ₩30.20 Billion ≈ $20.47 Million |
₩-4.31 Billion ≈ $-2.92 Million |
-0.143x | -- |
About Bioneer Corporation
Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analys… Read more